In the United States approved implementation of the first experiment to edit the human genome.
In the United States special Commission on biological security and ethics approved the holding of the first experiment to edit the human genome with the help of system programs CRISPR/Cas9.
Experimental Protocol the research therapy was created by researchers from the University laboratory. Development represents a transformation of T lymphocytes with antigenic hybrid end formations sensitive nerve fibers. Genetically-transformed lymphocytes using the endings allow you to enter into relationship with the cancer cells, triggering thus a reflex urge to destroy them.
According to the source, in the experiment, the biologists plan to use the system CRIPR for destruction in experimental rodents 2 genes included in the CAR-T-cells.
